Atlas Trials

SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis

Clinical trial NCT07495995 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07495995
Sponsor
Cedars-Sinai Medical Center
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Start date
2026-04-15
Primary completion
2030-12-31
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.